Cancer Treatment Holdings, Inc. (CTHZ)

0.0001 0.0000 (0.00%) At close: 10:29AM EDT

Cancer Treatment Holdings, Inc.

202 North Curry Street
Suite 100
Carson City, NV 89703
United States
212-221-1340

Sector(s): 
Industry: 
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Ullrich Klamm Ph.D.	Chairman of the Board, Chief Executive Officer, Chief Financial Officer and President	156.6k	N/A	1939

Amounts are as of December 31, 2002 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cancer Treatment Holdings, Inc., through its subsidiaries, engages in providing IT-enabled services; the exploitation of an invention related to the on-site production of chlorine gas and related compounds; and providing radiation therapy, diagnostic imaging, and other medical related services. The company, through a 50% interest in a joint venture, offers IT-enabled services, including medical transcriptions, billing and collecting, bookkeeping, and claims processing services. The company enables users to manufacture chlorine on-site and when needed through its device. It has a 51% interest in a radiation therapy center located in Logan, West Virginia. In addition, through its wholly owned subsidiary, CTI Management Corp., the company's president provides management services. The company was incorporated in 1986 and is based in Carson City, Nevada.

Corporate Governance

Cancer Treatment Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.